John Costigan Biography and Net Worth

Mr. John Costigan is Chief Data Officer at FactSet. In this role, he defines FactSet’s enterprise-wide Data Strategy and leads Data Development from planning through delivery. This includes Data's Digital Transformation using modern techniques and technology to drive timeliness, accuracy, coverage, consistency and usability across all FactSet Data assets. He joined the company in September 2007. Prior to FactSet, he was Vice President, Product Management at Thomson Financial, and spent 11 years in a variety of Product Management roles at First Call, Autex, ILX, and Tradeweb. Mr. Costigan earned a bachelor's degree in Economics from St. Michael's College.

What is John Costigan's net worth?: The estimated net worth of John Costigan is at least $187,554.15 as of October 16th, 2023. Mr. Costigan owns 445 shares of FactSet Research Systems stock worth more than $187,554 as of April 27th. This net worth estimate does not reflect any other assets that Mr. Costigan may own. Learn More about John Costigan's net worth.
How do I contact John Costigan?: The corporate mailing address for Mr. Costigan and other FactSet Research Systems executives is 45 GLOVER AVENUE, NORWALK CT, 06850. FactSet Research Systems can also be reached via phone at (203) 810-1000 and via email at [email protected]. Learn More on John Costigan's contact information.
Has John Costigan been buying or selling shares of FactSet Research Systems?: John Costigan has not been actively trading shares of FactSet Research Systems over the course of the past ninety days. Most recently, John Costigan sold 1,162 shares of the business's stock in a transaction on Monday, October 16th. The shares were sold at an average price of $450.97, for a transaction totalling $524,027.14. Following the completion of the sale, the insider now directly owns 445 shares of the company's stock, valued at $200,681.65. Learn More on John Costigan's trading history.
Who are FactSet Research Systems' active insiders?: FactSet Research Systems' insider roster includes Robin Abrams (Director), Scott Billeadeau (Director), John Costigan (Insider), Christopher Ellis (EVP), Gene Fernandez (Insider), Malcolm Frank (Director), Sheila Jordan (Director), James McGonigle (Director), Gregory Moskoff (CAO), Jonathan Reeve (EVP), Robert Robie (EVP), Laurie Siegel (Director), Goran Skoko (EVP), Philip Snow (CEO), Katherine Stepp (CTO), Rachel Stern (EVP), and Joseph Zimmel (Director). Learn More on FactSet Research Systems' active insiders.
Are insiders buying or selling shares of FactSet Research Systems?: During the last twelve months, insiders at the business services provider sold shares 15 times. They sold a total of 40,926 shares worth more than $18,297,051.36. The most recent insider tranaction occured on April, 1st when CEO Frederick Philip Snow sold 3,000 shares worth more than $1,356,300.00. Insiders at FactSet Research Systems own 1.0% of the company. Learn More about insider trades at FactSet Research Systems.
Information on this page was last updated on 4/1/2024.

John Costigan Insider Trading History at FactSet Research Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/16/2023	Sell	1,162	$450.97	$524,027.14	445

John Costigan Buying and Selling Activity at FactSet Research Systems

FactSet Research Systems Company Overview

FactSet Research Systems Inc., a financial data company, provides integrated financial information and analytical applications to the investment community in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company delivers insight and information through the workflow solutions of research, analytics and trading, content and technology solutions, and wealth. It serves portfolio managers, investment banks, asset managers, wealth advisors, corporate clients, and other financial services entities. FactSet Research Systems Inc. was founded in 1978 and is headquartered in Norwalk, Connecticut.

Today's Range

Now: $421.47

$417.82

$423.23

50 Day Range

MA: $450.55

$418.71

$487.69

2 Week Range

Now: $421.47

$380.96

$488.64

Volume

185,143 shs

Average Volume

241,371 shs

Market Capitalization

$16.06 billion

P/E Ratio

33.37

Dividend Yield

0.93%

Beta

0.72

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>